Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | glyceraldehyde 3 phosphate dehydrogenase | 0.0444 | 1 | 1 |
Loa Loa (eye worm) | glyceraldehyde 3-phosphate dehydrogenase | 0.0291 | 0.6018 | 0.9248 |
Trichomonas vaginalis | glyceraldehyde 3-phosphate dehydrogenase, putative | 0.0444 | 1 | 1 |
Toxoplasma gondii | glyceraldehyde-3-phosphate dehydrogenase GAPDH2 | 0.0444 | 1 | 1 |
Trypanosoma brucei | glyceraldehyde 3-phosphate dehydrogenase, glycosomal | 0.0444 | 1 | 1 |
Trypanosoma cruzi | glyceraldehyde 3-phosphate dehydrogenase, putative | 0.0444 | 1 | 1 |
Trichomonas vaginalis | glyceraldehyde 3-phosphate dehydrogenase, putative | 0.0444 | 1 | 1 |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Leishmania major | glyceraldehyde 3-phosphate dehydrogenase, glycosomal | 0.0444 | 1 | 1 |
Schistosoma mansoni | glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) | 0.0444 | 1 | 1 |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Trypanosoma brucei | glyceraldehyde 3-phosphate dehydrogenase, glycosomal | 0.0444 | 1 | 1 |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Onchocerca volvulus | Neuropeptide F receptor homolog | 0.0099 | 0.1039 | 0.5 |
Entamoeba histolytica | glyceraldehyde-3-phosphate dehydrogenase, putative | 0.0444 | 1 | 0.5 |
Leishmania major | glyceraldehyde 3-phosphate dehydrogenase, glycosomal | 0.0444 | 1 | 1 |
Brugia malayi | Glyceraldehyde 3-phosphate dehydrogenase | 0.0153 | 0.2434 | 0.1556 |
Plasmodium falciparum | glyceraldehyde-3-phosphate dehydrogenase | 0.0444 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0291 | 0.6018 | 0.9248 |
Echinococcus granulosus | glyceraldehyde 3 phosphate dehydrogenase | 0.0444 | 1 | 1 |
Entamoeba histolytica | glyceraldehyde-3-phosphate dehydrogenase, putative | 0.0444 | 1 | 0.5 |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Echinococcus granulosus | glyceraldehyde 3 phosphate dehydrogenase | 0.0444 | 1 | 1 |
Echinococcus multilocularis | glyceraldehyde 3 phosphate dehydrogenase | 0.0444 | 1 | 1 |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Loa Loa (eye worm) | glyceraldehyde-3-phosphate dehydrogenase | 0.0306 | 0.6422 | 1 |
Trichomonas vaginalis | glyceraldehyde 3-phosphate dehydrogenase, putative | 0.0291 | 0.6018 | 0.4737 |
Schistosoma mansoni | glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) | 0.0444 | 1 | 1 |
Trichomonas vaginalis | glyceraldehyde 3-phosphate dehydrogenase, putative | 0.0444 | 1 | 1 |
Schistosoma mansoni | glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) | 0.0444 | 1 | 1 |
Loa Loa (eye worm) | glyceraldehyde-3-phosphate dehydrogenase | 0.0306 | 0.6422 | 1 |
Echinococcus multilocularis | glyceraldehyde 3 phosphate dehydrogenase | 0.0291 | 0.6018 | 0.5556 |
Onchocerca volvulus | Dopamine\/Ecdysteroid receptor homolog | 0.0099 | 0.1039 | 0.5 |
Mycobacterium ulcerans | glyceraldehyde 3-phosphate dehydrogenase Gap | 0.0444 | 1 | 0.5 |
Trypanosoma cruzi | glyceraldehyde 3-phosphate dehydrogenase, cytosolic, putative | 0.0444 | 1 | 1 |
Brugia malayi | glyceraldehyde 3-phosphate dehydrogenase | 0.0138 | 0.2029 | 0.1105 |
Trypanosoma cruzi | glyceraldehyde-3-phosphate dehydrogenase, putative | 0.0291 | 0.6011 | 0.4996 |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Trypanosoma cruzi | glyceraldehyde-3-phosphate dehydrogenase, putative | 0.0291 | 0.6011 | 0.4996 |
Loa Loa (eye worm) | glyceraldehyde 3-phosphate dehydrogenase | 0.0291 | 0.6018 | 0.9248 |
Treponema pallidum | glyceraldehyde 3-phosphate dehydrogenase (gap) | 0.0444 | 1 | 0.5 |
Trypanosoma brucei | glyceraldehyde 3-phosphate dehydrogenase, cytosolic | 0.0444 | 1 | 1 |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Trypanosoma cruzi | glyceraldehyde 3-phosphate dehydrogenase, putative | 0.0444 | 1 | 1 |
Chlamydia trachomatis | glyceraldehyde-3-phosphate dehydrogenase | 0.0444 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable glyceraldehyde 3-phosphate dehydrogenase Gap (GAPDH) | 0.0153 | 0.244 | 0.5 |
Toxoplasma gondii | glyceraldehyde-3-phosphate dehydrogenase GAPDH1 | 0.0444 | 1 | 1 |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Wolbachia endosymbiont of Brugia malayi | glyceraldehyde-3-phosphate dehydrogenase, GapA | 0.0444 | 1 | 0.5 |
Trypanosoma cruzi | glyceraldehyde 3-phosphate dehydrogenase, cytosolic, putative | 0.0444 | 1 | 1 |
Trypanosoma cruzi | glyceraldehyde 3-phosphate dehydrogenase, putative | 0.0444 | 1 | 1 |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Trichomonas vaginalis | glyceraldehyde 3-phosphate dehydrogenase, putative | 0.0444 | 1 | 1 |
Entamoeba histolytica | glyceraldehyde-3-phosphate dehydrogenase, putative | 0.0444 | 1 | 0.5 |
Schistosoma mansoni | glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) | 0.0444 | 1 | 1 |
Giardia lamblia | Glyceraldehyde 3-phosphate dehydrogenase | 0.0444 | 1 | 1 |
Mycobacterium leprae | Probable glyceraldehyde 3-phosphate dehydrogenase Gap (GAPDH) | 0.0153 | 0.244 | 0.5 |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Echinococcus granulosus | glyceraldehyde 3 phosphate dehydrogenase | 0.0291 | 0.6018 | 0.5556 |
Trichomonas vaginalis | glyceraldehyde 3-phosphate dehydrogenase, putative | 0.0444 | 1 | 1 |
Trypanosoma cruzi | glyceraldehyde 3-phosphate dehydrogenase, cytosolic, putative | 0.0444 | 1 | 1 |
Trypanosoma cruzi | glyceraldehyde 3-phosphate dehydrogenase, putative | 0.0444 | 1 | 1 |
Plasmodium vivax | glyceraldehyde-3-phosphate dehydrogenase, putative | 0.0444 | 1 | 0.5 |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Trichomonas vaginalis | glyceraldehyde 3-phosphate dehydrogenase, putative | 0.0291 | 0.6018 | 0.4737 |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 | |
Onchocerca volvulus | 0.0099 | 0.1039 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.